Unknown

Dataset Information

0

Using deep learning to identify bladder cancers with FGFR-activating mutations from histology images.


ABSTRACT:

Background

In recent years, the fibroblast growth factor receptor (FGFR) pathway has been proven to be an important therapeutic target in bladder cancer. FGFR-targeted therapies are effective for patients with FGFR mutation, which can be discovered through genetic sequencing. However, genetic sequencing is not commonly performed at diagnosis, whereas a histologic assessment of the tumor is. We aim to computationally extract imaging biomarkers from existing tumor diagnostic slides in order to predict FGFR alterations in bladder cancer.

Methods

This study analyzed genomic profiles and H&E-stained tumor diagnostic slides of bladder cancer cases from The Cancer Genome Atlas (n = 418 cases). A convolutional neural network (CNN) identified tumor-infiltrating lymphocytes (TIL). The percentage of the tissue containing TIL ("TIL percentage") was then used to predict FGFR activation status with a logistic regression model.

Results

This predictive model could proficiently identify patients with any type of FGFR gene aberration using the CNN-based TIL percentage (sensitivity = 0.89, specificity = 0.42, AUROC = 0.76). A similar model which focused on predicting patients with only FGFR2/FGFR3 mutation was also found to be highly sensitive, but also specific (sensitivity = 0.82, specificity = 0.85, AUROC = 0.86).

Conclusion

TIL percentage is a computationally derived image biomarker from routine tumor histology that can predict whether a tumor has FGFR mutations. CNNs and other digital pathology methods may complement genome sequencing and provide earlier screening options for candidates of targeted therapies.

SUBMITTER: Velmahos CS 

PROVIDER: S-EPMC8290253 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7943565 | biostudies-literature
| S-EPMC8511039 | biostudies-literature
| S-EPMC7921635 | biostudies-literature
| S-EPMC7935886 | biostudies-literature
| S-EPMC8226179 | biostudies-literature
| S-EPMC7688140 | biostudies-literature
| S-EPMC8027374 | biostudies-literature
| S-EPMC7364471 | biostudies-literature
| S-EPMC8609154 | biostudies-literature
| 2117958 | ecrin-mdr-crc